Brian J Ball (Brian Ball)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

African American

Acute Myeloid Leukemia

Hematopoietic Stem Cell

Top Venues

American journal of hematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Philipp Bewersdorf, Shai Shimony, Rory Michael Shallis, Yiwen Liu, Guillaume Berton, Eva Johanna Schaefer, Amer M Zeidan, Aaron D Goldberg, Eytan M Stein, Guido Marcucci, Rebecca Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Miguel Ramos Perez, Anthony S Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Intensive Induction Chemotherapy versus Hypomethylating Agents in Combination with Venetoclax in NPM1-mutant AML. Blood advances (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology 99 (8) (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology 99 (8) (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology 99 (8) (2024)
Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Z Pourhassan, Vaibhav Agrawal, Paul Koller, Shukaib Arslan, Vanina Tomasian, Monzr M Al Malki, Andrew Artz, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S Sandhu, Brian J Ball, Salman Otoukesh, Idoroenyi Amanam, Pamela S Becker, Forrest M Stewart, Peter Curtin, Eileen Smith, Milhan Telatar, Anthony S Stein, Guido Marcucci, Stephen J Forman, Ryotaro Nakamura, Vinod A Pullarkat
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. American journal of hematology (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology 98 (4) (2023)
Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Z Pourhassan, Vaibhav Agrawal, Paul B Koller, Shukaib Arslan, Vanina Tomasian, Monzr M Al Malki, Andrew Artz, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S Sandhu, Brian J Ball, Salman Otoukesh, Idoroenyi Amanam, Pamela S Becker, Forrest M Stewart, Peter Curtin, Eileen Smith, Milhan Telatar, Anthony S Stein, Guido Marcucci, Stephen J Forman, Ryotaro Nakamura, Vinod A Pullarkat
High Response Rates and Transition to Transplant after Novel Targeted and Cellular Therapies in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia with Philadelphia-Like Fusions. American journal of hematology (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology 98 (4) (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology 98 (4) (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with CMV Triplex augments frequencies of functional and durable CMV-specific T cells in the recipient: a novel strategy to limit antiviral prophylaxis. American journal of hematology (2023)
Brian J Ball, Shukaib Arslan, Paul Koller, Dat Ngo, Michelle Afkhami, Amandeep Salhotra, Monzr M Al Malki, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Salman Otoukesh, Idoroenyi Amanam, Hoda Z Pourhassan, Andrew S Artz, Peter Curtin, Anthony Stein, Ryotaro Nakamura, Guido Marcucci, Eileen Smith, Vinod A Pullarkat, Ibrahim Aldoss
Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML). Leukemia & lymphoma (2022)
Hoda Z Pourhassan, Dongyun Yang, Michelle Afkhami, Raju Pillai, Brian J Ball, Monzr M Al Malki, Amandeep Salhotra, Haris Ali, Andrew Artz, Peter Curtin, Saro Armenian, Anthony Stein, Stephen J Forman, Guido Marcucci, Vinod A Pullarkat, Ryotaro Nakamura, Ibrahim Aldoss
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia. American journal of hematology 97 (5) (2022)
Jan Philipp Bewersdorf, Rory Michael Shallis, Andriy Derkach, Aaron D Goldberg, Anthony Stein, Eytan M Stein, Guido Marcucci, Amer M Zeidan, Shai Shimony, Daniel J DeAngelo, Richard M Stone, Ibrahim Aldoss, Brian J Ball, Maximilian Stahl
Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors. Leukemia & lymphoma (2022)
Brian J Ball, Meier Hsu, Sean M Devlin, Maria Arcila, Mikhail Roshal, Yanming Zhang, Chris A Famulare, Aaron D Goldberg, Sheng F Cai, Andrew Dunbar, Zachary Epstein-Peterson, Kamal N Menghrajani, Jacob L Glass, Justin Taylor, Aaron D Viny, Sergio S Giralt, Boglarka Gyurkocza, Brian C Shaffer, Roni Tamari, Ross L Levine, Martin S Tallman, Eytan M Stein
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy. American journal of hematology 96 (5) (2021)